Skip Ribbon Commands
Skip to main content

NHG Fund

Our Fundraising Campaigns

Fight Infectious Diseases
The current COVID-19 pandemic has affected the lives of many. The National Centre for Infectious Diseases (NCID), a NHG institution, is at the forefront of our fight against COVID-19 and many other infectious diseases. As we fight this ongoing pandemic, we face other infectious diseases such as Antimicrobial resistance – a serious health threat as microorganisms become resistant to the drugs designed to destroy them. NCID is finding solutions to save lives from these infectious diseases.

COVID-19: Racing to get ahead of coronavirus
Currently, World Health Organization acknowledged the possibility of airborne transmission in crowded indoor spaces, such as in choir practice, restaurants and fitness classes. More research is needed to investigate if airborne transmission is a significant driver of the COVID-19 pandemic.

A recent NCID study shown parts of the coronavirus existing in particles smaller than 4 microns which are capable of transmitting through air. NCID is studying if the coronavirus is naturally airborne, and infectious in such a form. Experiments are carried out in airborne infection isolation rooms and in communal living settings to study if the virus is viable in the air. This helps us to understand COVID-19 transmission better so as to ensure good infection control practices and advice to the public.

NCID is also conducting other studies to keep the pandemic under control:
·         Studying the long-term effects of COVID-19 infection

·         Assessment of available Rapid Diagnostic test kits for use at GP clinics, Polyclinics and emergency rooms

Protecting lives from antimicrobial resistance

Besides combating sudden outbreaks such as COVID-19, we are constantly fighting existing diseases such as antibiotic resistance too.

Matthew was 39 years old when what started as a sore throat turned into a life-threatening, drug-resistant infection. His body went into toxic shock. To save his life, doctors had to amputate his arms and legs. Matthew beat the odds and survived.

Antibiotic resistance is a serious global health threat as bacteria become superbugs - resistant to antibiotics and therefore able to multiply and become stronger. Without effective antibiotics, medical procedures such as surgery, cancer chemotherapy and organ transplant would be dangerous. By 2050, it is estimated that antibiotic resistance will cause more deaths than cancer.

Antibiotic-resistant infections affect people from all walks of life – young and old, healthy and chronically ill. The infections often start with something benign such as a seemingly harmless sore throat or ear infection.

We seek your support for our infectious diseases research and innovation to protect lives.

Partner us in our quest to fight emerging and existing infectious diseases. For online donations, please click here to access our Giving.sg fundraising campaign. For donations via other methods, please refer to our "How to donate" section.

Save Limbs, Save Lives – Research to reduce limb amputation due to diabetes
Singapore has one of the highest rates of limb amputations in the world – an average of 4 amputations per day. Our diabetes research aims to reduce limb amputations among those living with diabetes in Singapore. We want to predict, prevent and detect early diabetes complications such as tissue death that requires limb amputations.

Our research team at Tan Tock Seng Hospital, a part of NHG, is developing an effective method to detect blood vessel damage. This allows us to identify patients with diabetes who are at high risk of limb amputations.

You can save limbs and lives by making a donation to support our work. For online donations, please click here to access our Giving.sg fundraising campaign. For donations via other methods, please refer to the "How to donate" section.